The DOI matches its Crossref record; 43 of the 44 references it cites were found in a registry or an index.
Blocking Hypoxia-Induced Autophagy in Tumors Restores Cytotoxic T-Cell Activity and Promotes Regression
Published version of a preprint
Abstract
The relationship between hypoxic stress, autophagy, and specific cell-mediated cytotoxicity remains unknown. This study shows that hypoxia-induced resistance of lung tumor to cytolytic T lymphocyte (CTL)–mediated lysis is associated with autophagy induction in target cells. In turn, this correlates with STAT3 phosphorylation on tyrosine 705 residue (pSTAT3) and HIF-1α accumulation. Inhibition of autophagy by siRNA targeting of either beclin1 or Atg5 resulted in impairment of pSTAT3 and restoration of hypoxic tumor cell susceptibility to CTL-mediated lysis. Furthermore, inhibition of pSTAT3 in hypoxic Atg5 or beclin1-targeted tumor cells was found to be associated with the inhibition Src kinase (pSrc). Autophagy-induced pSTAT3 and pSrc regulation seemed to involve the ubiquitin proteasome system and p62/SQSTM1. In vivo experiments using B16-F10 melanoma tumor cells indicated that depletion of beclin1 resulted in an inhibition of B16-F10 tumor growth and increased tumor apoptosis. Moreover, in vivo inhibition of autophagy by hydroxychloroquine in B16-F10 tumor-bearing mice and mice vaccinated with tyrosinase-related protein-2 peptide dramatically increased tumor growth inhibition. Collectively, this study establishes a novel functional link between hypoxia-induced autophagy and the regulation of antigen-specific T-cell lysis and points to a major role of autophagy in the control of in vivo tumor growth. Cancer Res; 71(18); 5976–86. ©2011 AACR.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Normoxic and hypoxic stabilization of HIF signaling in tumor cells promotes resistance to cytotoxic T lymphocyte–mediated lysis”
From Hypoxic control of metastasis (2016) · cites this paper as [54]
In the citing paper
“the increased resistance of hypoxic tumor cells to CTL-mediated lysis. This increased resistance to CD8 T cell-mediated killing is correlated with the hypoxic induction of tumor cell autophagy [86, 87].”
From Hypoxia and hypoxia-inducible factors as regulators of T cell development, differentiation, and function (2013) · cites this paper as [87]
Citations
Cites
Autophagy in the Pathogenesis of Disease
Levine, B., & Kroemer, G. (2008) · Cell · doi:10.1016/j.cell.2007.12.018 · Cited by 7,069
Cancer immunotherapy: moving beyond current vaccines
Rosenberg, S. A., Yang, J. C.-H., & Restifo, N. P. (2004) · Nature Medicine · doi:10.1038/nm1100 · Cited by 2,980
Bromberg, J. F., Wrzeszczynska, M. H., Devgan, G., Zhao, Y., Pestell, R. G., Albanese, C., & Darnell, J. E. (1999) · Cell · doi:10.1016/s0092-8674(00)81959-5 · Cited by 2,790
Rosenberg, S. A., Yang, J. C., Schwartzentruber, D. J., Hwu, P., Marincola, F. M., Topalian, S. L., Restifo, N. P., Dudley, M. E., Schwarz, S. L., Spiess, P. J., et al. (1998) · Nature Medicine · doi:10.1038/nm0398-321 · Cited by 1,786
Bellot, G., Garcia-Medina, R., Gounon, P., Chiche, J., Roux, D., Pouysségur, J., & Mazure, N. M. (2009) · Molecular and Cellular Biology · doi:10.1128/mcb.00166-09 · Cited by 1,501
Autophagy inhibition enhances therapy-induced apoptosis in a Myc-induced model of lymphoma
Amaravadi, R. K., Yu, D., Lum, J. J., Bui, T., Christophorou, M. A., Evan, G. I., Thomas‐Tikhonenko, A., & Thompson, C. B. (2007) · Journal of Clinical Investigation · doi:10.1172/jci28833 · Cited by 1,158
Integration of Oxygen Signaling at the Consensus HRE
Wenger, R. H., Stiehl, D. P., & Camenisch, G. (2005) · Science's STKE · doi:10.1126/stke.3062005re12 · Cited by 1,032
Potential therapeutic applications of autophagy
Rubinsztein, D. C., Gestwicki, J. E., Murphy, L. O., & Klionsky, D. J. (2007) · Nature Reviews Drug Discovery · doi:10.1038/nrd2272 · Cited by 862
Rouschop, K. M. A., van den Beucken, T., Dubois, L., Niessen, H., Bussink, J., Savelkouls, K., Keulers, T., Mujcic, H., Landuyt, W., Voncken, J. W., et al. (2010) · Journal of Clinical Investigation · doi:10.1172/jci40027 · Cited by 829
Ding, W.-X., Ni, H.-M., Gao, W., Yoshimori, T., Stolz, D. B., Ron, D., & Yin, X.-M. (2007) · The American Journal of Pathology · doi:10.2353/ajpath.2007.070188 · Cited by 708
Hypoxia-induced autophagy: cell death or cell survival?
Mazure, N. M., & Pouysségur, J. (2009) · Current Opinion in Cell Biology · doi:10.1016/j.ceb.2009.11.015 · Cited by 646
HIF-1 as a target for drug development
Giaccia, A., Siim, B. G., & Johnson, R. S. (2003) · Nature Reviews Drug Discovery · doi:10.1038/nrd1199 · Cited by 631
Autophagy Inhibition Compromises Degradation of Ubiquitin-Proteasome Pathway Substrates
Korolchuk, V. I., Mansilla, A., Menzies, F. M., & Rubinsztein, D. C. (2009) · Molecular Cell · doi:10.1016/j.molcel.2009.01.021 · Cited by 610
(2001) · PubMed · Cited by 605
Xu, Q., Briggs, J., Park, S., Niu, G., Kortylewski, M., Zhang, S., Gritsko, T., Turkson, J., Kay, H. D., Semenza, G. L., et al. (2005) · Oncogene · doi:10.1038/sj.onc.1208719 · Cited by 582
Mechanisms of cross‐talk between the ubiquitin‐proteasome and autophagy‐lysosome systems
Korolchuk, V. I., Menzies, F. M., & Rubinsztein, D. C. (2009) · FEBS Letters · doi:10.1016/j.febslet.2009.12.047 · Cited by 581
Adding Chloroquine to Conventional Treatment for Glioblastoma Multiforme
Sotelo, J., Briceño, E., & López-González, M. A. (2006) · Annals of Internal Medicine · doi:10.7326/0003-4819-144-5-200603070-00008 · Cited by 511
Dalby, K. N., Tekedereli, İ., Lopez‐Berestein, G., & Özpolat, B. (2010) · Autophagy · doi:10.4161/auto.6.3.11625 · Cited by 449
COP9 signalosome‐specific phosphorylation targets p53 to degradation by the ubiquitin system
Bech‐Otschir, D., Kraft, R., Huang, X., Henklein, P., Kapelari, B., Pollmann, C., & Dubiel, W. (2001) · The EMBO Journal · doi:10.1093/emboj/20.7.1630 · Cited by 396
The host—tumor immune conflict: from immunosuppression to resistance and destruction
Chouaı̈b, S., Asselin‐Paturel, C., Mami‐Chouaib, F., Caignard, A., & Blay, J. (1997) · Immunology Today · doi:10.1016/s0167-5699(97)01115-8 · Cited by 353
Self-citationChloroquine potentiates the anti-cancer effect of 5-fluorouracil on colon cancer cells
Sasaki, K., Tsuno, N. H., Sunami, E., Tsurita, G., Kawai, K., Okaji, Y., Nishikawa, T., Shuno, Y., Hongo, K., Hiyoshi, M., et al. (2010) · BMC Cancer · doi:10.1186/1471-2407-10-370 · Cited by 322
Enhancing Immunity Through Autophagy
Münz, C. (2008) · Annual Review of Immunology · doi:10.1146/annurev.immunol.021908.132537 · Cited by 269
Huang, S. (2007) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-06-2313 · Cited by 251
Vucicevic, L., Misirkic, M., Kristina, J., Vilimanovich, U., Sudar, E., Isenovic, E., Prica, M., Harhaji-Trajkovic, L., Kravic-Stevovic, T., Vladimir, B., et al. (2011) · Autophagy · doi:10.4161/auto.7.1.13883 · Cited by 227
Lukashev, D., Klebanov, B., Kojima, H., Grinberg, A., Ohta, A., Berenfeld, L., Wenger, R. H., Ohta, A., & Sitkovsky, M. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.177.8.4962 · Cited by 208
Lisanti, M. P., Martinez-Outschoorn, U. E., Chiavarina, B., Pavlides, S., Whitaker-Menezes, D., Tsirigos, A., Witkiewicz, A. K., Lin, Z., Balliet, R. M., Howell, A., et al. (2010) · Cancer Biology & Therapy · doi:10.4161/cbt.10.6.13370 · Cited by 199
Hypoxia-induced autophagy contributes to the chemoresistance of hepatocellular carcinoma cells
Song, J., Qu, Z., Guo, X., Zhao, Q., Zhao, X., Gao, L., Sun, K., Shen, F., Wu, M., & Wei, L. (2009) · Autophagy · doi:10.4161/auto.5.8.9996 · Cited by 195
Noman, M. Z., Buart, S., Van Pelt, J., Richon, C., Hasmim, M., Leleu, N., Suchorska, W. M., Jalil, A., Lecluse, Y., El Hage, F., et al. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0800854 · Cited by 183
Self-citationChloroquine inhibits cell growth and induces cell death in A549 lung cancer cells
Fan, C., Wang, W., Zhao, B., Zhang, S., & Miao, J. (2006) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2005.12.035 · Cited by 176
Hypoxia-activated autophagy accelerates degradation of SQSTM1/p62
Pursiheimo, J.-P., Rantanen, K., Heikkinen, P. T., Johansen, T., & Jaakkola, P. (2008) · Oncogene · doi:10.1038/onc.2008.392 · Cited by 155
Cho, H.-I., & Celis, E. (2009) · Cancer Research · doi:10.1158/0008-5472.can-09-2019 · Cited by 142
Progress in the development of immunotherapy for the treatment of patients with cancer
Rosenberg, S. A. (2001) · Journal of Internal Medicine · doi:10.1046/j.1365-2796.2001.00911.x · Cited by 124
HIF-1 Inhibitors for Cancer Therapy: From Gene Expression to Drug Discovery
Semenza, G. (2009) · Current Pharmaceutical Design · doi:10.2174/138161209789649402 · Cited by 116 · cited 1×
“Signaling pathways involving hypoxia-inducible factor HIF-1a (11) and hypoxia-dependent activation of STAT3 (12) have been well elucidated (13).”
Targeting hypoxia tolerance in cancer
Wouters, B. G. (2004) · Drug Resistance Updates · doi:10.1016/j.drup.2003.12.004 · Cited by 90
Zheng, Y., Zhao, Y., Deng, X., Yang, S., Mao, Y.-Q., Li, Z., Jiang, P., Zhao, X., & Wei, Y. (2009) · Cancer Investigation · doi:10.1080/07357900802427927 · Cited by 88
Is Autophagy the Key Mechanism by Which the Sphingolipid Rheostat Controls the Cell Fate Decision?
Lavieu, G., Scarlatti, F., Sala, G., Levade, T., Ghidoni, R., Botti, J., & Codogno, P. (2007) · Autophagy · doi:10.4161/auto.3416 · Cited by 87
Hamaï, A., Benlalam, H., Meslin, F., Hasmim, M., Carré, T., Akalay, I., Janji, B., Berchem, G., Noman, M. Z., & Chouaı̈b, S. (2009) · Tissue Antigens · doi:10.1111/j.1399-0039.2009.01401.x · Cited by 77
Self-citationMagnon, C., Opolon, P., Ricard, M., Connault, E., Ardouin, P., Galaup, A., Métivier, D., Bidart, J., Germain, S., Perricaudet, M., et al. (2007) · Journal of Clinical Investigation · doi:10.1172/jci30269 · Cited by 65
The immune system as anti-tumor sentinel: molecular requirements for an anti-tumor immune response.
Markiewicz, M. A., & Gajewski, T. F. (1999) · PubMed · Cited by 50
Chouaı̈b, S. (2003) · Journal of Clinical Investigation · doi:10.1172/jci18044 · Cited by 28
Kochenderfer, J. N., Chien, C. D., Simpson, J. L., & Gress, R. E. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.177.12.8860 · Cited by 26
Chairman’s Summary: Mechanisms of Oxygen Homeostasis, Circa 1999
Semenza, G. L. (2002) · Advances in experimental medicine and biology · doi:10.1007/0-306-46825-5_29 · Cited by 19
Insulin stimulation of PKCδ triggers its rapid degradation via the ubiquitin-proteasome pathway
Brand, C., Horovitz‐Fried, M., Inbar, A., Tamar-Brutman-Barazani, Brodie, C., & Sampson, S. R. (2010) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2010.07.006 · Cited by 7
Cited by
Sorted by citations
Rankin, E. B., & Giaccia, A. J. (2016) · Science · doi:10.1126/science.aaf4405 · Cited by 1,340
PAMP s and DAMP s: signal 0s that spur autophagy and immunity
Tang, D., Kang, R., Coyne, C. B., Zeh, H. J., & Lotze, M. T. (2012) · Immunological Reviews · doi:10.1111/j.1600-065x.2012.01146.x · Cited by 1,327
HIF transcription factors, inflammation, and immunity
Palazon, A., Goldrath, A. W., Nizet, V., & Johnson, R. S. (2014) · Immunity · doi:10.1016/j.immuni.2014.09.008 · Cited by 1,195
Targeting Autophagy in Cancer: Recent Advances and Future Directions
Amaravadi, R. K., Kimmelman, A. C., & Debnath, J. (2019) · Cancer Discovery · doi:10.1158/2159-8290.cd-19-0292 · Cited by 928
Cancer Stem Cells: The Architects of the Tumor Ecosystem
Prager, B. C., Xie, Q., Bao, S., & Rich, J. N. (2019) · Cell stem cell · doi:10.1016/j.stem.2018.12.009 · Cited by 608
Metadata
- Authors
- Noman, M. Z., Janji, B., Kaminska, B., Van Moer, K., Pierson, S., Przanowski, P., Buart, S., Berchem, G., Romero, P., Mami-Chouaib, F., & Chouaib, S.
- Affiliations
- Inserm (FR)
- Authors' Affiliations: 1Unité INSERM U753, Institut de Cancérologie Gustave Roussy, Villejuif Cedex, France; 2Laboratory of Experimental Hemato-Oncology, Department of Oncology, Public Research Center for Health (CRP-Santé), Luxembourg City, Luxembourg; 3Laboratory of Transcription Regulation, Department of Cell Biology, Nencki Institute, Warsaw, Poland; and 4Translational Tumor Immunology group, Ludwig Center for Cancer Research, University of Lausanne, Lausanne, Switzerland
- Venue
- Cancer Research
- Published
- 2011-09-13
- Volume
- 71
- Issue
- 18
- Pages
- 5976-5986
- ISSN
- 0008-5472 (ISSN-L)
- 1538-7445
- OpenAlex
- W2151713424
- Cited by
- 256
- References
- 44
- Citations by year
- 2026: 8 · 2025: 2 · 2024: 15 · 2023: 15 · 2022: 30 · 2021: 30 · 2020: 24 · 2019: 16 · 2018: 16 · 2017: 16 · 2016: 23 · 2015: 11 · 2014: 14 · 2013: 19 · 2012: 12
- FWCI
- 12.00
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Cancer Research (publishedVersion)
- PubMed (publishedVersion)
- IRIS (submittedVersion)
- SERVAL (Université de Lausanne) (submittedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Autophagy in Disease and Therapy
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Hypoxia, and Metabolism
- Health Sciences › Medicine › Oncology › Cancer Immunotherapy and Biomarkers
- Keywords
- tumor hypoxia, autophagy, cytotoxic T lymphocytes, STAT3 phosphorylation, HIF-1α, Beclin-1, ATG5, Src kinase, ubiquitin-proteasome system, p62, tumor regression, B16F10 melanoma, hydroxychloroquine, tumor immunology
- MeSH terms
- Sequestosome-1 Protein, Animals, Autophagy, Heat-Shock Proteins, Humans, Lung Neoplasms, Melanoma, Experimental, Mice, Inbred C57BL, Phosphorylation, T-Lymphocytes, Cytotoxic, Cell Hypoxia, src-Family Kinases, Ubiquitin, Cell Line, Tumor, Proteasome Endopeptidase Complex, Adaptor Proteins, Signal Transducing, STAT3 Transcription Factor, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review